Literature DB >> 10719009

The patient's burden: physical and psychological effects of acute exacerbations of chronic bronchitis.

P Nicolson1, P Anderson.   

Abstract

In this prospective qualitative study we evaluated the subjective perspectives of the quality of life of patients with chronic bronchitis. Individuals with diagnoses which fulfilled the clinical criteria of chronic bronchitis, i.e. daily production of sputum for at least three consecutive months in two consecutive years, were recruited into four focus groups from general practices in two industrial cities. Younger patients (those of pre-retirement age) of both sexes-a significant, but frequently 'invisible' minority in this patient population-were targeted. The groups were constituted with the aim of stimulating variation in the discussions. Twenty sufferers (10 males and 10 females, ranging in age from 30 to 86 years) were eventually included in the study; there were five in each group. Group discussions were recorded and transcribed verbatim and the data were analysed thematically. It was evident from the discussions that chronic bronchitis had led to a high degree of psychological distress in the participants, particularly in relation to dependency on medication, and disruption of social and family relationships. Acute exacerbations of chronic bronchitis (AECB) were met with dread. They brought about further reductions in quality of life, increased anxieties about breathlessness, fear of atmospheric pollution and of changes in and extremes of temperature, embarrassment about coughing up phlegm in public and suspicion of medical practitioners' motives if they were unwilling to prescribe antibiotics on request. Patients' health-related behaviour and beliefs were often contradictory. For example, AECB in some patients led to increased smoking. There were also gender and age differences; for example, it was the perception of males that they received more support from their partners than did females. Younger participants appeared more distressed by AECB than older ones. The results of this study suggest that raising the standard of care for patients with chronic bronchitis requires that greater attention be paid to patients' subjective experiences of the disease.

Entities:  

Mesh:

Year:  2000        PMID: 10719009     DOI: 10.1093/jac/45.suppl_2.25

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.

Authors:  Sanjay Sethi; John Breton; Brian Wynne
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 2.  Experiences of living and dying with COPD: a systematic review and synthesis of the qualitative empirical literature.

Authors:  M Giacomini; D DeJean; D Simeonov; A Smith
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01

3.  Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil.

Authors:  Jose-Luis Alvarez-Sala; Peter Kardos; Jesús Martínez-Beltrán; Pilar Coronel; Lorenzo Aguilar
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

4.  Acute exacerbations of chronic bronchitis: a pharmacoeconomic review of antibacterial use.

Authors:  Stephen Morris; Pippa Anderson; Debra E Irwin
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 5.  Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature.

Authors:  Helen Doll; Marc Miravitlles
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

6.  Changes in health status, psychological distress, and quality of life in COPD patients after hospitalization.

Authors:  Randi Andenaes; Torbjørn Moum; Mary H Kalfoss; Astrid K Wahl
Journal:  Qual Life Res       Date:  2006-03       Impact factor: 4.147

Review 7.  Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review.

Authors:  Alison Pooler; Roger Beech
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-03-29

8.  Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy.

Authors:  S Saint; K R Flaherty; P Abrahamse; F J Martinez; A M Fendrick
Journal:  Clin Ther       Date:  2001-03       Impact factor: 3.393

9.  Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI).

Authors:  Alexander Chuchalin; Maryna Zakharova; Dejan Dokic; Mahir Tokić; Hans-Peter Marschall; Thomas Petri
Journal:  BMC Pulm Med       Date:  2013-01-23       Impact factor: 3.317

Review 10.  Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.

Authors:  Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.